Applied Evidence

Recognizing and treating trigger finger

Author and Disclosure Information

 

References

While the location of the injection has been debated, recent literature suggests that symptoms can be effectively alleviated regardless of the specific anatomic injection site, such as intra-sheath or extra-sheath (FIGURE 2).19 This allows flexibility for the clinician, as the injection does not have to be placed within the tendon sheath. Corticosteroids should not be injected into the tendon itself, and the needle tip should be slightly withdrawn if there is resistance while injecting. Patients who are averse to injections have been shown to benefit from needle-free jet lidocaine (J-tip) administration prior to the actual steroid injection.20

A corticosteroid injection at the A1 pulley provides relief

A randomized controlled trial comparing dexamethasone to triamcinolone injections found no difference in outcome at the 3-month follow-up (n = 84).17 This may suggest that the choice of corticosteroid is at the clinician’s discretion. In terms of long-term efficacy of steroid injections, it has been shown that 70% of trigger digits had complete resolution of symptoms at a mean follow-up of 8 years after just 1 injection (n = 43).21

Some patients, though, may require additional corticosteroid injections to maintain symptom control. If multiple injections are performed, they should not be given in intervals shorter than 4 months between treatments.5 Furthermore, steroids can be administered safely up to 3 times in the same digit before surgery is recommended.22

A patient’s options should be reconsidered if efficacy is not demonstrated with prior injections. Notably, a lower success rate has been shown in patients with type 2 diabetes (66%) compared to those without diabetes (90%).4,23 This difference in success rates is not well understood, as there is no causal relationship between well-controlled diabetes and TF.4 Complications of corticosteroid injections include local pain, fat atrophy, and hypopigmentation at the site of the injection, as well as short-term elevations in blood glucose levels in patients with diabetes.5,24

Surgical correction (to be discussed) remains superior to steroid injections in terms of cure rate and resolution of symptoms. A randomized controlled trial (n = 165) found that an injection-only group reported 86% and 49% success at 3-month and 12-month follow-up, respectively, compared to 99% success at both 3- and 12-month follow-up for the surgical group. Further, at 12-month follow-up, the median pain scores were significantly higher in the injection group (3; range, 1-9) than in the surgery group (1; range, 1-7).25 If conservative treatment modalities lead to unresolved symptoms or recurrence, referral to a hand specialist for surgery is recommended.

Continue to: Surgical treatments in an office setting

Pages

Recommended Reading

‘Deeper dive’ into opioid overdose deaths during COVID pandemic
MDedge Family Medicine
‘Lopioid protocol’ – low-dose opioids – proposed for fracture surgery
MDedge Family Medicine
Growing proportion of cardiac arrests in U.S. considered opioid related
MDedge Family Medicine
Case: Patient with statin-associated muscle symptoms
MDedge Family Medicine
Most muscle pain on statins not a drug effect: SAMSON in print
MDedge Family Medicine
Assessing headache severity via migraine symptoms can help predict outcomes
MDedge Family Medicine
Opioid overdoses tied to lasting cognitive impairment
MDedge Family Medicine
As opioid deaths climb, human trials begin for vaccine
MDedge Family Medicine
Step-wise medical therapy is cost effective for endometriosis
MDedge Family Medicine
Guideline gives weak support to trying oral medical cannabis for chronic pain
MDedge Family Medicine